General

New evidence that cancer cells change while moving throughout body. For the majority of cancer patients, it's not the primary tumor that is deadly, but the spread or "metastasis" of cancer cells from the primary tumor to secondary locations throughout the body that is the problem.

That's why a major focus of contemporary cancer research is how to stop or fight metastasis. Previous lab studies suggest that metastasizing cancer cells undergo a major molecular change when they leave the primary tumor – a process called epithelial-to-mesenchymal transition (EMT). As the cells travel from one site to another, they pick up new characteristics. More importantly, they develop a resistance to chemotherapy that is effective on the primary tumor. But confirmation of the EMT process has only taken place in test tubes or in animals. In a new study, published in the Journal of Ovarian Research, Georgia Tech scientists have direct evidence that EMT takes place in humans, at least in ovarian cancer patients. 'Dark-horse' molecule is a potential new anti-cancer target. Australian researchers have identified a molecule called interleukin-11 as a potential new target for anti-cancer therapies.

Until now, the importance of interleukin-11 in cancer development has been underestimated, but researchers have recently identified this molecule as a 'dark horse' for the development of cancer. Their discovery suggests blocking interleukin-11 signalling could ultimately provide an exciting new approach to the treatment of bowel and stomach cancer, which are two of the most common cancers worldwide. When a tumour develops, the normal (non-cancerous) tissues around it can become inflamed, and produce many different molecules, including the two related proteins interleukin-11 and interleukin-6. These hormone-like signalling molecules, referred to as cytokines, are thought to promote the growth and spread of cancer cells, but interleukin-11 was thought to have only a minor, if any, role during cancer development.

Medical Patch Kills Cancer Cells In Hard-To-Target Places [Video] York University student researchers Zakareya Hussein and Atif Syed have launched a crowdfunding campaign to develop a nanoparticle cancer treatment that will be applied to the skin via a pharmaceutical patch.

Nanject is a patch that injects microscopic particles or nanoparticles into the bloodstream. These nanoparticles will then target cancer cells and attach themselves to the cancer cells and kill them. The particles and dead cells will then be removed naturally by the body. The crowdfunding campaign is aimed not just to raise funds for the research of the cancer treatment, but to also study other ways of delivering such treatment. The team specifically wants to do more research on targeted drug delivery. New wonder drug matches and kills all kinds of cancer. Kanker Spoken. Chemotherapy Medicine For Children Rebranded As Superhero Superformula.

Advertisement I can’t imagine what it’s like to have a child with cancer.

It must be one of the most difficult and scary things a family could ever go through, and the children are always incredibly courageous. 'Kanker over twintig jaar zelden dodelijk' Indiana, PA - 'Flocking' raises Relay for Life funds. The yard of Dianna Rostis on Country Lane in White Township was “flocked” with pink flamingos recently in a fundraising effort for the Relay for Life later this month.

(Tom Peel/Gazette) No Side Effects With New Cancer Radiation Treatment - Health News. April 3, 2013 Lee Rannals for redOrbit.com — Your Universe Online Scientists have developed a new form of radiation therapy that successfully put cancer into remission in mice.

The new treatment did not produce any harmful side effects typically seen with conventional chemo and radiation cancer therapies. The team says clinical trials in humans could begin as soon as funding is secured. “Since the 1930s, scientists have sought success with a cancer treatment known as boron neutron capture therapy (BNCT),” said University of Missouri Curators´ Professor M. The Conspiracy To End Cancer. The hero scientist who defeats cancer will likely never exist.

No exalted individual, no victory celebration, no Marie Curie or Jonas Salk, who in 1955, after he created the first polio vaccine, was asked, So what’s next? Cancer? — as if a doctor finished with one disease could simply shift his attention to another, like a chef turning from the soup to the entrée. Nederlands Tijdschrift voor Geneeskunde. Stomach Cancer Breathalyzer Test Makes Detection Easy. This article titled “Stomach cancer breath test trialled successfully” was written by Sarah Boseley, health editor, for guardian.co.uk on Wednesday 6th March 2013 12.07 UTC Scientists have successfully trialled a simple breath test to detect stomach cancer, using a new type of sensor made of nanomaterials. The first trial of the device is small, involving 130 patients with a range of different stomach complaints, but it proved to be more than 90% accurate in differentiating between cancer and other diseases.

It was also over 90% accurate in detecting which were early-stage cancers and which were advanced. It has been known for some time that cancers can give off odours that may not be detectable to the human nose. A study published by German researchers in 2010 described how dogs had been trained to sniff out lung cancers – although they accepted it was possible the dogs were picking up the smell of drugs used to treat patients rather than the disease. Kanker in Beeld. Kaal staan we sterk, Jeannette van Mierlo. Links. Welkom 1 2. Welkom 1. Couple-based interventions may help improve the psychological wellbeing of cancer patients and their partners, but more research is needed. Cancer diagnosis and treatment can have negative consequences for the psychological wellbeing of patients and their caregivers.

This blog will summarise a systematic review on whether couple-based interventions make a difference for couples affected by cancer (Regan, 2012). The review tried to answer three questions: What is the efficacy of couple-based interventions on depression, anxiety, distress, or quality of life? How is the content of the couple-based interventions tailored and delivered? What elements of these interventions seem to be most effective in reducing distress and improving outcomes for patients and partners? Methods The authors searched a range of databases that helped identify the interventions that targeted both the patient and their partners.

The authors used PRISMA guidelines to maximise methodological quality of their review. According the EPHPP criteria, eight studies had a global rating of ‘strong’ and the remainder were ‘moderate’. A Shot at Cancer - America's Health Checkup. Correction Appended: Sept. 15, 2009 Back in 1999, two researchers at the National Cancer Institute (NCI) received a long-awaited green light to launch separate studies on cancer care.

Six months apart, Dr. Douglas Schwartzentruber and Dr. Cancer Dream Teams: Road to a Cure? Group-think is that latest trend in cancer research.

This week’s cover story, available to subscribers here, explains why such team efforts are becoming a necessity, and why it hasn’t always been this way. Scientists used to think they knew a lot about how cancer works, and they do. But only over the last couple of years, led by major advances in genomics, have they been able to truly understand the biological workings of this leading killer. And the knowledge has been both helpful and humbling. Cancer, it turns out, is way more complex than many scientists imagined. That’s been the premise behind Stand Up 2 Cancer’s Dream Team approach and it is gaining traction.

Gene Therapy Could Expand Treatment Options for Cancer. <br/><a href=" US News</a> | <a href=" Business News</a> Copy A clinical trial using a patient's own immune system to produce remissions in adults with acute leukemia could be a major breakthrough in the fight against all different kinds of cancer. The new study, published Wednesday in the journal Science Translational Medicine, took five patients with untreatable cancer, and using their own immune systems, injected genetic material into the patient's white cells to turn them into cancer fighters. The modified white cells then went out in the body and destroyed all the cancer cells, causing the patients to go into remission, according to the study. "Cancer cells are similar enough to your normal cells that the T-cells cannot recognize it," Dr.

KWF Kankerbestrijding - Home. Lessons I've learned from a colon cancer patient. I have been installed as President of the Alabama Academy of Family Physicians. The work should not be too hard and on occasion should be rewarding (or at least ego-boosting). Such was the case the other day when the executive director asked me to recall a patient from “my early days” that had made an impact so he could publish my thoughts, thus officially making me an old geezer. I thought back, thinking of the the heavy snow drifts I walked through to get to the hospital (unusual weather in Portsmouth), recalling the large hill that I had to walk up to get both there and back, and this was the patient’s story I chose.

Untitled. Levend Echt. Over loslaten & bewegen. Welkom op kanker.nl. Love life. Fight cancer. - Fight cancer. The broad spectrum of unbearable suffering in end-of-life cancer studied in Dutch primary care. Research article Cees DM Ruijs13*, Ad JFM Kerkhof23†, Gerrit van der Wal13† and Bregje D Onwuteaka-Philipsen13† * Corresponding author: Cees DM Ruijs c.ruys3@kpnplanet.nl † Equal contributors Author Affiliations 1 Department of Public and Occupational Health, VU University Medical Centre, Amsterdam, The Netherlands 2 Department of Clinical Psychology, VU University, Amsterdam, The Netherlands 3 EMGO + Institute for Health and Care Research, Palliative Care Centre of Expertise, VU University Medical Centre, Amsterdam, The Netherlands For all author emails, please log on.

BMC Palliative Care 2012, 11:12 doi:10.1186/1472-684X-11-12 Published: 1 August 2012. The leading oncology channel. The White Room - Oncology Media Resource Centre from Boehringer Ingelheim. Effectiveness of Multidimensional Cancer Survivor Rehabilitation and Cost-Effectiveness of Cancer Rehabilitation in General: A Systematic Review. Watson Is Now Commercially Available, Set To Help Doctors Treat Cancer. [Source: ibmbusinessanalytics via YouTube] IBM’s most promising medical student just graduated and is ready to join the workforce and help people – in the fight against cancer, to be specific. IBM has just released a commercially available Watson whose cognitive computing could help doctors make better diagnoses and smarter treatment choices.

IBM has partnered with WellPoint, Inc. and Memorial Sloan-Kettering Cancer Center to train Watson in oncology and utilization management. A team of clinicians and technicians spent thousands of hours “teaching” Watson how to process, analyze, and interpret complex clinical information through natural language processing. The hope is that Watson can help raise the quality of healthcare and make it more efficient.